Top Markets
#1 Akedo Akedo +59.38%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.41%
#4 Velvet Velvet +39.92%
#5 Black Phoenix Black Phoenix +34.56%
#6 Ο„emplar Ο„emplar +23.53%
#7 Ribbita by Virtuals Ribbita by Virtuals +17.77%
#8 Cross Cross +15.77%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +15.57%
#10 Bitway Bitway +15.46%
Coin of the day
Akedo Akedo
Settings
Language
ENGLISH
Currency
USD
Theme
Psyence Group Inc. Psyence Group Inc.

Psyence Group Inc.

PSYG
Rank in Stocks #38237
Psyence Group Inc. is a life sciences biotechnology company primarily engaged... Psyence Group Inc. is a life sciences biotechnology company primarily engaged in the commercial cultivation and production of psilocybin mushrooms. This naturally sourced psilocybin is intended for therapeutic applications, addressing a broad spectrum of mental health conditions and other medical ailments. The company is actively formulating pharmaceutical-grade psilocybin treatments designed to mitigate psychological trauma and recognized disorders such as anxiety, depression, post-traumatic stress disorder (PTSD), and the emotional distress linked to grief and bereavement. Furthermore, Psyence Group develops, distributes, and sells over-the-counter functional mushroom nutraceuticals, entirely free of psilocybin, under its GOODMIND brand. Established in 2019, the company maintains its headquarters in Toronto, Canada.
Share Price
$0.08765138
Last synced: 2025-12-23
Market Cap
$1.11M
Change (1 day)
0.45%
Change (1 year)
-28.78%
Country
CA
Trade Psyence Group Inc. (PSYG)

Category

Healthcare
Stock price history for Psyence Group Inc. (PSYG)
Highest end of day price: $0.09 on 2025-12-01

Lowest end of day price: $0.17 on 2021-01-01
Stock price history of Psyence Group Inc. from 2021 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 10.84%
2025 -20.78%
2024 -39.49%
2023 111.53%
2022 -39.61%
2021 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $1.18K 72.71%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $260.38 49.03%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $249.16 21.73%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $470.54 44.82%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $135.64 63.90%
US